Stiefel Laboratories acquires ABR Invent and ABR Development

May 8, 0008

Coral Gables, Fla. - Stiefel Laboratories announces the acquisition of ABR Invent and ABR Development, developers of the dermal filler Atlean, PRNewswire reports.

Coral Gables, Fla.

- Stiefel Laboratories announces the acquisition of ABR Invent and ABR Development, developers of the dermal filler Atlean, PRNewswire reports.

Stiefel will acquire all shares of ABR Invent and ABR Development through a definitive stock purchase agreement. Both Invent and Development are based in France.

Atlean(R) is a bio-resorbable, sculpting and modeling dermal filler with hyaluronic acid and tricalcium phosphate particles. Atlean(R) received a CE-Mark granted in 2006 and is marketed in France and Italy, according to PRNewswire.

Related Content:

News